Biolegend, 317416, APC anti-human CD4 Antibody, 100tests

CD4, also known as T4, is a 55 kD single-chain type I transmembrane glycoprotein expressed on most thymocytes, a subset of T cells, and monocytes/macrophages. CD4, a member of the Ig superfamily, recognizes antigens associated with MHC class II molecules and participates in cell-cell interactions, thymic differentiation, and signal transduction. CD4 acts as a primary receptor for HIV, binding to HIV gp120. CD4 has also been shown to interact with IL-16.
100tests
Verified Reactivity: Human, Cynomolgus, Rhesus
Reported Reactivity: Chimpanzee
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: Human peripheral T cells
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Red Laser (633 nm)
Application Notes: The OKT4 antibody binds to the D3 domain of CD4 and does not block HIV binding. Additional reported applications (for the relevant formats) include: immunohistochemistry of frozen sections and blocking of T cell activation. This clone was tested in-house and does not work on formalin fixed paraffin-embedded (FFPE) tissue. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 317453 and 317454). In a small subset of individuals, the OKT4 clone does not bind to CD4 due to polymorphisms in CD4.9
Application References(PubMed link indicates BioLegend citation): Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York. Reinherz EL, et al. 1979. Proc. Natl. Acad. Sci. 76:4061. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed Cicin-Sain L, et al. 2010. J. Immunol. 184:6739. PubMed Rosenzweig M, et al. 2001. J. Med. Primatol. 30:36. Linder J, et al. 1987. Am. J. Pathol. 127:1. Boche D, et al. 1999. J. Neurovirol. 5:232. (IHC) Reinherz EL, et al. 1979. Proc. Natl. Acad. Sci. USA. 76:4061. (Immunogen) Lederman S, et al. 1991. Mol Immunol. 28:1171-81.
Product Citations: Soday L, et al. 2021. Frontiers in Immunology. 12:600056. PubMed Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed Carre C, et al. 2021. iScience. 24:102970. PubMed Wang T, et al. 2022. Front Immunol. 13:954121. PubMed Mitchell JL, et al. 2022. J Clin Invest. 132: . PubMed Höfle J, et al. 2022. EMBO Rep. 23:e54133. PubMed Wang CQ, et al. 2023. Cells. 12: . PubMed Zhang W, et al. 2022. Dev Cell. 57:329. PubMed Uhlenbrock F, et al. 2014. J Immunol. 193:1654. PubMed Claiborne DT, et al. 2019. PLoS Pathog. 15:e1007981. PubMed Mete B, et al. 2022. Life Sci Alliance. 5:. PubMed Azizi E et al. 2018. Cell. 174(5):1293-1308 e36. PubMed Want MY, et al. 2019. Oncoimmunology. 8:e1586042. PubMed Sun J, et al. 2018. Scand J Immunol. 88:e12674. PubMed Ahmed R et al. 2019. Cell. 177(6):1583-1599 . PubMed Saadati S, et al. 2020. Avicenna J Med Biotechnol. 0.591666667. PubMed Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed Dushyanthen S, et al. 2017. Nat Commun. 10.1038/s41467-017-00728-9. PubMed Wang Z, et al. 2021. Cell Mol Immunol. 18:2188. PubMed Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed Acerbi E, et al. 2016. Sci Rep. 6:23128. PubMed Altman K 2006. J Immunol . 177:1721. PubMed Li N, et al. 2021. STAR Protoc. 2:100942. PubMed Bellini N, et al. 2022. iScience. 25:105234. PubMed Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed Narsale A, Moya R, Robertson H 2016. Data Brief. 8: 1348-51. PubMed Sugita S, et al. 2016. Stem Cell Reports. 7:619-634. PubMed Arif S, et al. 2020. Diabetologia. 63(6):1186-1198.. PubMed Alsaleh G, et al. 2020. Elife. 9: . PubMed Jiang H, et al. 2021. Oncoimmunology. 10:1943180. PubMed Wang A, et al. 2020. Front Immunol. 1.213194444. PubMed Zhang J, et al. 2022. Nature. 609:369. PubMed Johnson A, et al. 2016. mSphere. 1: e00288-16. PubMed Bigler M, et al. 2015. PLoS One. 10: 0145635. PubMed Berezhnoy A, et al. 2020. Cell Rep Med. 1:100163. PubMed Jafari M, et al. 2014. J Virol. 88:5062. PubMed Kim K, et al. 2019. Nat Microbiol. 1.586111111. PubMed Frencher J, et al. 2014. J Leukoc Biol. 96:957. PubMed Li N, et al. 2020. Oncoimmunology. 9:1824643. PubMed Li N, et al. 2021. Cell Rep Med. 2:100297. PubMed Dahal S, et al. 2022. Retrovirology. 19:18. PubMed Bossini-Castillo L, et al. 2022. Cell Genom. 2:. PubMed Dupont L, et al. 2021. Cell Host Microbe. 29(5):792-805.e6. PubMed Mishra A, et al. 2021. Cell. 184(13):3394-3409.e20. PubMed Cirelli KM et al. 2019. Cell. 177(5):1153-1171 . PubMed Roy S, et al. 2021. Nat Commun. 12:3182. PubMed Ledderose C, et al. 2021. J Leukoc Biol. 109:497. PubMed Comte D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9321 - 9326. PubMed Su Y, et al. 2020. Cell. 1479:183. PubMed Mujib S, et al. 2017. JCI Insight. 2:e93687. PubMed Reyes M, et al. 2021. Sci Transl Med. 13:. PubMed Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed Siedlik J, et al. 2017. J Immunol Methods. 10.1016/j.jim.2017.03.017. PubMed Sashihara J, et al. 2011. PLoS One. 6:e1002308. PubMed Okutani Y, et al. 2022. Tissue Eng Part A. 28:94. PubMed Dotson A, et al. 2013. Clin Immunol. 148:149. PubMed Kang HM, et al. 2018. Nat Biotechnol. 36:89. PubMed
RRID: AB_571944 (BioLegend Cat. No. 317415) AB_571945 (BioLegend Cat. No. 317416)
Structure: Ig superfamily, type I transmembrane glycoprotein, 55 kD
Distribution: T cell subset, majority of thymocytes, monocytes/macrophages
Function: MHC class II co-receptor, lymphocyte adhesion, thymic differentiation, HIV receptor
Ligand/Receptor: MHC class II molecules, HIV gp120, IL-16
Cell Type: Macrophages, Monocytes, T cells, Thymocytes, Tregs
Biology Area: Immunology
Molecular Family: CD Molecules
Antigen References: 1. Center D, et al. 1996. Immunol. Today 17:476. 2. Gaubin M, et al. 1996. Eur. J. Clin. Chem. Clin. Biochem. 34:723.
Gene ID: 920
UniProt: View information about CD4 on UniProt.org
Clone: OKT4
Regulatory Status: RUO
Workshop: HCDM listed
Other Names: T4
Isotype: Mouse IgG2b, κ
Q: I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
A: TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.